The immune-mediated alteration of serotonin and glutamate: towards an integrated view of depression
The DOI matches its Crossref record; 218 of the 220 references it cites were found in a registry or an index.
Abstract
Beside the well-known deficiency in serotonergic neurotransmission as pathophysiological correlate of major depression (MD), recent evidence points to a pivotal role of increased glutamate receptor activation as well. However, cause and interaction of these neurotransmitter alterations are not understood. In this review, we present a hypothesis integrating current concepts of neurotransmission and hypothalamus-pituitary-adrenal (HPA) axis dysregulation with findings on immunological alterations and alterations in brain morphology in MD. An immune activation including increased production of proinflammatory cytokines has repeatedly been described in MD. Proinflammatory cytokines such as interleukin-2, interferon-gamma, or tumor necrosis factor-alpha activate the tryptophan- and serotonin-degrading enzyme indoleamine 2,3-dioxygenase (IDO). Depressive states during inflammatory somatic disorders are also associated with increased proinflammatory cytokines and increased consumption of tryptophan via activation of IDO. An enhanced consumption of serotonin and its precursor tryptophan through IDO activation could well explain the reduced availability of serotonergic neurotransmission in MD. An increased activation of IDO and its subsequent enzyme kynurenine monooxygenase by proinflammatory cytokines, moreover, leads to an enhanced production of quinolinic acid, a strong agonist of the glutamatergic N-methyl-D-aspartate receptor. In inflammatory states of the central nervous system, IDO is mainly activated in microglial cells, which preferentially metabolize tryptophan to the NMDA receptor agonist quinolinic acid, whereas astrocytes - counteracting this metabolism due to the lack of an enzyme of this metabolism - have been observed to be reduced in MD. Therefore the type 1/type 2 immune response imbalance, associated with an astrocyte/microglia imbalance, leads to serotonergic deficiency and glutamatergic overproduction. Astrocytes are further strongly involved in re-uptake and metabolic conversion of glutamate. The reduced number of astrocytes could contribute to both, a diminished counterregulation of IDO activity in microglia and an altered glutamatergic neurotransmission. Further search for antidepressant agents should take into account anti-inflammatory drugs, for example, cyclooxygenase-2 inhibitors, might exert antidepressant effects by acting on serotonergic deficiency, glutamatergic hyperfunction and antagonizing neurotoxic effects of quinolinic acid.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“An alternative explanation for the involvement of IDO in the pathophysiology of depression-like behaviour is that degradation of tryptophan along the kynurenine pathway generates compounds that act as either agonists (for example, quinolinic acid and 3 hydroxy-kynurenine) or antagonists (for example, kynurenic acid) of the NMDA (N-methyl-D-aspartate) receptor (BOX 1).”
From From inflammation to sickness and depression: when the immune system subjugates the brain (2008) · cites this paper as [61]
In the citing paper
“cytokine-induced activation of the enzyme, indolamine 2,3 dioxygenase (IDO), which metabolizes tryptophan to kynurenine and quinolinic acid, is believed to contribute to reduced availability of serotonin.16,23,24”
From Cytokines and Glucocorticoid Receptor Signaling (2009) · cites this paper as [23]
In the citing paper
“one hypothesis postulates that proinflammatory cytokines stimulate indoleamine 2,3-dioxygenase (IDO) in glial cells to convert tryptophan to kynurenine which is transformed into the neurotoxic quinolinic acid inside the brain (Müller and Schwarz, 2007;Walker et al., 2014).”
From A Review of the Relationship between Proinflammatory Cytokines and Major Depressive Disorder (2014) · cites this paper as Müller and Schwarz, 2007
In the citing paper
“kynurenic acid is an N-methyl d-aspartate (NMDA) receptor antagonist, and is generally considered neuroprotective”
From Glucocorticoids, cytokines and brain abnormalities in depression (2011) · cites this paper as Müller and Schwarz, 2007
Citations
Cites
Danbolt, N. C. (2001) · Progress in Neurobiology · doi:10.1016/s0301-0082(00)00067-8 · Cited by 4,227
Rates and risk of postpartum depression – a meta-analysis
O'hara, M. W., & Swain, A. M. (1996) · International Review of Psychiatry · doi:10.3109/09540269609037816 · Cited by 3,116
Cytokines sing the blues: inflammation and the pathogenesis of depression
Raison, C. L., Capuron, L., & Miller, A. H. (2006) · Trends in Immunology · doi:10.1016/j.it.2005.11.006 · Cited by 3,009
Davis, H. S. (1966) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1966.03100200106038 · Cited by 1,719
Inhibition of T Cell Proliferation by Macrophage Tryptophan Catabolism
Munn, D. H., Shafizadeh, E., Attwood, J. T., Bondarev, I., Pashine, A., & Mellor, A. L. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.9.1363 · Cited by 1,623
Glial reduction in the subgenual prefrontal cortex in mood disorders
Öngür, D., Drevets, W. C., & Price, J. L. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.22.13290 · Cited by 1,525
Immunoregulatory Feedback Between Interleukin-1 and Glucocorticoid Hormones
Besedovsky, H., del Rey, A., Sorkin, E., & Dinarello, C. A. (1986) · Science · doi:10.1126/science.3014662 · Cited by 1,519
Rajkowska, G., Miguel-Hidalgo, J. J., Wei, J., Dilley, G., Pittman, S. D., Meltzer, H. Y., Overholser, J. C., Roth, B. L., & Stockmeier, C. A. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00041-4 · Cited by 1,477
Cytokine-Associated Emotional and Cognitive Disturbances in Humans
Reichenberg, A., Yirmiya, R., Schuld, A., Kraus, T., Haack, M., Morag, A., & Pollmächer, T. (2001) · Archives of General Psychiatry · doi:10.1001/archpsyc.58.5.445 · Cited by 1,365
Cytokines and major depression
Schiepers, O. J. G., Wichers, M. C., & Maes, M. (2005) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2004.11.003 · Cited by 1,235
Research works printed but not linked: 5
- Matussek N . Neurobiologie und depression. Med Monatsschr 1966; 3: 109–112.
- Abou-Saleh MT, Ghubash R, Karim L, Krymski M, Anderson DN . The role of pterins and related factors in the biology of early postpartum depression. Eur Neuropsychopharmacol 1999; 9: 295–300.
- Rajkowska G . Astroglia in the cortex of schizophrenics: histopathology finding. World J Biol Psychiatry 2005; 6: 74.
- Thomas K . Immunomodulation in Mice Induced by the Antidepressant Drug Zimeldine. Thesis, University of Utrecht: Utrecht, 1989.
- Song C, Leonard BE . An acute phase protein response in the olfactory bulbectomised rat: effect of sertraline treatment. Med Sci Res 1994; 22: 313–314.
Cited by
Items 101–200 of 681
Maternal separation induces neuroinflammation and long-lasting emotional alterations in mice
Gracia-Rubio, I., Moscoso-Castro, M., Pozo, O. J., Marcos, J., Nadal, R., & Valverde, O. (2016) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2015.09.003 · Cited by 144
Inflammation in depression: is adiposity a cause?
C. Shelton, R., & H. Miller, A. (2011) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2011.13.1/rshelton · Cited by 141
Bortolato, B., F. Carvalho, A., K. Soczynska, J., I. Perini, G., & S. McIntyre, R. (2015) · Current Neuropharmacology · doi:10.2174/1570159x13666150630171433 · Cited by 142
The importance of cytokines and autoantibodies in depression
Postal, M., & Appenzeller, S. (2014) · Autoimmunity Reviews · doi:10.1016/j.autrev.2014.09.001 · Cited by 154
Toxoplasmosis as a cause for behaviour disorders - overview of evidence and mechanisms
Fekadu, A., Shibre, T., & Cleare, A. J. (2010) · Folia Parasitologica · doi:10.14411/fp.2010.013 · Cited by 141
Mitochondrial dysfunction: A fatal blow in depression
Song, Y., Cao, H., Zuo, C., Gu, Z., Huang, Y., Miao, J., Fu, Y., Guo, Y., Jiang, Y., & Wang, F. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115652 · Cited by 156
Fu, X., Zunich, S. M., O'Connor, J. C., Kavelaars, A., Dantzer, R., & Kelley, K. W. (2010) · Journal of Neuroinflammation · doi:10.1186/1742-2094-7-43 · Cited by 130
Diet-Derived Fatty Acids, Brain Inflammation, and Mental Health
Melo, H. M., Santos, L. E., & Ferreira, S. T. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00265 · Cited by 136
“Furthermore, increased kynurenine metabolism may result in excessive production of 3-hydroxykynurenine, a generator of reactive oxygen species (ROS), and quinolinic acid, an NMDA receptor agonist, both of which could have their own implications to depression (Müller and Schwarz, 2007).”
BackgroundD'Mello, C., & Swain, M. G. (2011) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00184.2011 · Cited by 133
Lotrich, F. E., Ferrell, R. E., Rabinovitz, M., & Pollock, B. G. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.08.009 · Cited by 136
Novel neuroimmunologic therapeutics in depression: A clinical perspective on what we know so far
Roman, M., & Irwin, M. R. (2020) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2019.09.016 · Cited by 132
“which further reduces tryptophan hydroxylase driven serotonin (5-HT) synthesis (Muller and Schwarz, 2007; Zoga et al., 2014).”
BackgroundZinc: indications in brain disorders
Prakash, A. K., Bharti, K., & Majeed, A. B. A. (2015) · Fundamental and Clinical Pharmacology · doi:10.1111/fcp.12110 · Cited by 138
Setoyama, D., Kato, T. A., Hashimoto, R., Kunugi, H., Hattori, K., Hayakawa, K., Sato-Kasai, M., Shimokawa, N., Kaneko, S., Yoshida, S., et al. (2016) · PLOS ONE · doi:10.1371/journal.pone.0165267 · Cited by 125
Clarke, G., Fitzgerald, P., Cryan, J. F., Cassidy, E. M., Quigley, E. M., & Dinan, T. G. (2009) · BMC Gastroenterology · doi:10.1186/1471-230x-9-6 · Cited by 128
Malynn, S., Campos‐Torres, A., Moynagh, P. N., & Haase, J. K. (2013) · Neurochemical Research · doi:10.1007/s11064-012-0967-y · Cited by 143
Ertenli, İ., Ozer, S., Kiraz, S., Apras, S., Akdoğan, A., Karadağ, Ö., Çalgünerı, M., & Kalyoncu, U. (2010) · Rheumatology International · doi:10.1007/s00296-010-1616-x · Cited by 140
Astrocyte pathology in the prefrontal cortex impairs the cognitive function of rats
Lima, A., Sardinha, V. M., Oliveira, A. F., dos Reis, M. I. F., Mota, C., Silva, M., Marques, F., Cerqueira, J., Pinto, L., Sousa, N., et al. (2014) · Molecular Psychiatry · doi:10.1038/mp.2013.182 · Cited by 143
Depression: Biological markers and treatment
Nedic Erjavec, G., Sagud, M., Nikolac Perkovic, M., Svob Strac, D., Konjevod, M., Tudor, L., Uzun, S., & Pivac, N. (2021) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2020.110139 · Cited by 119
Inflammatory Biomarkers and Depression
Müller, N., Myint, A.-M., & Schwarz, M. (2010) · Neurotoxicity Research · doi:10.1007/s12640-010-9210-2 · Cited by 144
Self-citationThe putative neurodegenerative links between depression and Alzheimer's disease
Wuwongse, S., Chang, R. C., & Law, A. C. K. (2010) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2010.04.005 · Cited by 133
Gałecki, P., Szemraj, J., Bieńkiewicz, M., Zboralski, K., & Gałecka, E. (2009) · Human Psychopharmacology: Clinical and Experimental · doi:10.1002/hup.1014 · Cited by 124
Clarke, G., McKernan, D. P., Gaszner, G., Quigley, E. M., Cryan, J. F., & Dinan, T. G. (2012) · Frontiers in Pharmacology · doi:10.3389/fphar.2012.00090 · Cited by 120
The Role of Indoleamine 2,3-Dioxygenase in a Mouse Model of Neuroinflammation-Induced Depression
Dobos, N., de Vries, E. F. J., Kema, I. P., Patas, K., Prins, M., Nijholt, I. M., Dierckx, R. A., Korf, J., den Boer, J. A., Luiten, P. G. M., et al. (2012) · Journal of Alzheimer's Disease · doi:10.3233/jad-2011-111097 · Cited by 118
Gut-brain axis metabolic pathway regulates antidepressant efficacy of albiflorin
Zhao, Z.-X., Fu, J., Ma, S.-R., Peng, R., Yu, J.-B., Cong, L., Pan, L.-B., Zhang, Z.-G., Tian, H., Che, C.-T., et al. (2018) · Theranostics · doi:10.7150/thno.28068 · Cited by 126
Hoyo-Becerra, C., Schlaak, J., & Hermann, D. M. (2014) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2014.06.200 · Cited by 131
Horikawa, H., Kato, T. A., Mizoguchi, Y., Monji, A., Seki, Y., Ohkuri, T., Gotoh, L., Yonaha, M., Ueda, T., Hashioka, S., et al. (2010) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.07.015 · Cited by 131
Association of social and cognitive impairment and biomarkers in autism spectrum disorders
Alabdali, A., Al-Ayadhi, L., & El-Ansary, A. (2014) · Journal of Neuroinflammation · doi:10.1186/1742-2094-11-4 · Cited by 117
“Although it is accepted that neuroinflammation can alter neurotransmitter function and its transporters [22] producing cognitive, behavioral, and psychiatric impairments, and that excess central nervous system (CNS) glutamate levels can induce neurotoxicity-mediated inflammation [23-26], the interaction between these…”
BackgroundSystemic inflammation induces anxiety disorder through CXCL12/CXCR4 pathway
Yang, L., Wang, M., Guo, Y., Sun, T., Li, Y., Yang, Q., Zhang, K., Liu, S.-B., Zhao, M., & Wu, Y. (2016) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2016.03.001 · Cited by 122
Shared genetic factors in migraine and depression: Evidence from a genetic isolate
van der Stam, A. H., de Vries, B., Janssens, A. C. J. W., Vanmolkot, K. R. J., Aulchenko, Y. S., Henneman, P., Oostra, B. A., Frants, R. R., van den Maagdenberg, A. M. J. M., Ferrari, M. D., et al. (2010) · Neurology · doi:10.1212/wnl.0b013e3181cbcd19 · Cited by 111
van Vuren, E. J., Steyn, S. F., Brink, C. B., Möller, M., Viljoen, F. P., & Harvey, B. H. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.111200 · Cited by 111
Kang, A., Hao, H., Zheng, X., Liang, Y., Xie, Y., Xie, T., Dai, C., Zhao, Q., Wu, X., Xie, L., et al. (2011) · Journal of Neuroinflammation · doi:10.1186/1742-2094-8-100 · Cited by 104
Gibney, S. M., Fagan, E. M., Waldron, A.-M., O‘Byrne, J., Connor, T. J., & Harkin, A. (2014) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145713001673 · Cited by 101
Neuropsychiatric disease in murine lupus is dependent on the TWEAK/Fn14 pathway
Wen, J., Xia, Y., Stock, A. D., Michaelson, J. S., Burkly, L. C., Gulinello, M. E., & Putterman, C. (2013) · Journal of Autoimmunity · doi:10.1016/j.jaut.2013.03.002 · Cited by 103
Slavich, G. M., Giletta, M., Helms, S. W., Hastings, P. D., Rudolph, K. D., Nock, M. K., & Prinstein, M. J. (2020) · Depression and Anxiety · doi:10.1002/da.22987 · Cited by 84
Pandharipande, P. P., Morandi, A., Adams, J. R., Girard, T. D., Thompson, J. L., Shintani, A. K., & Ely, E. W. (2009) · Intensive Care Medicine · doi:10.1007/s00134-009-1573-6 · Cited by 102
Tryptophan degradation in autoimmune diseases
Opitz, C. A., Wick, W., Steinman, L., & Platten, M. (2007) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-007-7140-9 · Cited by 118
The exploration of mechanisms of comorbidity between migraine and depression
Zhang, Q., Shao, A., Jiang, Z., Tsai, H., & Liu, W. (2019) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.14390 · Cited by 109
Serlin, Y., Levy, J., & Shalev, H. (2011) · Cardiovascular Psychiatry and Neurology · doi:10.1155/2011/609202 · Cited by 99
How does the skeletal muscle communicate with the brain in health and disease?
Isaac, A. R., Lima‐Filho, R. A. S., & Lourenco, M. V. (2021) · Neuropharmacology · doi:10.1016/j.neuropharm.2021.108744 · Cited by 104
Glymphatic Dysfunction Induced Oxidative Stress and Neuro-Inflammation in Major Depression Disorders
Gu, S., Li, Y., Jiang, Y., Huang, J. H., & Wang, F. (2022) · Antioxidants · doi:10.3390/antiox11112296 · Cited by 114
Liu, H., Luiten, P. G. M., Eisel, U. L. M., DeJongste, M. J. L., & Schoemaker, R. G. (2013) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2013.02.004 · Cited by 101
Inserra, A., Mastronardi, C. A., Rogers, G., Licinio, J., & Wong, M.-L. (2019) · Molecular Neurobiology · doi:10.1007/s12035-018-1359-3 · Cited by 96
Role of brain transmigrating neutrophils in depression-like behavior during systemic infection
Aguliar-Valles, A., Kim, J., Jung, S., Woodside, B., & Luheshi, G. N. (2014) · Molecular Psychiatry · doi:10.1038/mp.2013.137 · Cited by 97
Metabotropic glutamate receptor 7: At the interface of cognition and emotion
O’Connor, R. M., Finger, B. C., Flor, P. J., & Cryan, J. F. (2010) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2010.02.059 · Cited by 103
Review: the role of inflammation in depression.
Patel, A. J. (2013) · PubMed · Cited by 120
Jager, A., Sleijfer, S., & van der Rijt, C. C. D. (2008) · European Journal of Cancer · doi:10.1016/j.ejca.2007.11.023 · Cited by 110
Brand, S., Moller, M., & Harvey, B. (2015) · Current Neuropharmacology · doi:10.2174/1570159x13666150307004545 · Cited by 95
Citalopram reduces endotoxin-induced fatigue
Hannestad, J., DellaGioia, N., Ortiz, N., Pittman, B., & Bhagwagar, Z. (2011) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2010.10.013 · Cited by 95
Polyzos, K. A., & Ketelhuth, D. F. J. (2015) · Hämostaseologie · doi:10.5482/hamo-14-10-0052 · Cited by 94
Importance of fatigue and its measurement in chronic liver disease
Gerber, L. H., Weinstein, A. A., Mehta, R., & Younossi, Z. M. (2019) · World Journal of Gastroenterology · doi:10.3748/wjg.v25.i28.3669 · Cited by 100
Clark, S. M., Pocivavsek, A., Nicholson, J. D., Notarangelo, F. M., Langenberg, P., McMahon, R. P., Kleinman, J. E., Hyde, T. M., Stiller, J., Postolache, T. T., et al. (2016) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.150226 · Cited by 94
Draper, A., Koch, R. M., van der Meer, J. W., AJ Apps, M., Pickkers, P., Husain, M., & van der Schaaf, M. E. (2018) · Neuropsychopharmacology · doi:10.1038/npp.2017.231 · Cited by 91
Müller, N., Myint, A.-M., & Schwarz, M. J. (2009) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2009.11.3/nmueller · Cited by 93
Self-citationCommon mechanisms of pain and depression: are antidepressants also analgesics?
Nekovářová, T., Yamamotová, A., Valeš, K., Stuchlík, A., Fricová, J., & Rokyta, R. (2014) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2014.00099 · Cited by 101
Coplan, J. D., Gopinath, S., Abdallah, C. G., & Berry, B. R. (2014) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2014.00189 · Cited by 90
“Proinflammatory cytokines, such as interferon-γ, tumor necrosis factorα, interleukin-6, and others, divert tryptophan from serotonin biosynthesis to quinolinic acid production through the kynurenic acid pathway, thereby decreasing serotonin production (Muller and Schwarz, 2007).”
BackgroundDean, B. (2011) · International Journal of Neuropsychopharmacology · doi:10.1017/s1461145710001410 · Cited by 88
Anti-inflammatory treatment in schizophrenia
Müller, N., Myint, A.-M., Krause, D., Weidinger, E., & Schwarz, M. J. (2013) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2012.11.008 · Cited by 89
Self-citationUdina, M., Navinés, R., Egmond, E., Oriolo, G., Langohr, K., Gimenez, D., Valdés, M., Gómez-Gil, E., Grande, I., Gratacós, M., et al. (2016) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyv135 · Cited by 88
Brinn, A., & Stone, J. (2020) · BMJ Open · doi:10.1136/bmjopen-2020-036859 · Cited by 85
Microglia autophagy in ischemic stroke: A double-edged sword
Li, P., Hu, G., Yao, Q., Wu, J., He, Z., Law, B. Y. K., Hu, G., Zhou, X., Du, J., Wu, A., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1013311 · Cited by 89
SANDSTRÖM, A., PETERSON, J., SANDSTRÖM, E., LUNDBERG, M., NYSTROM, I. R., NYBERG, L., & OLSSON, T. (2011) · Scandinavian Journal of Psychology · doi:10.1111/j.1467-9450.2010.00844.x · Cited by 82
Targeting astrocytes in major depression
Peng, L., Verkhratsky, A., Gu, L., & Li, B. (2015) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2015.1095094 · Cited by 81
New findings: Depression, suicide, and Toxoplasma gondii infection
Hsu, P.-C., Groer, M. E., & Beckie, T. M. (2014) · Journal of the American Association of Nurse Practitioners · doi:10.1002/2327-6924.12129 · Cited by 97
Cognitive and Behavioral Consequences of Impaired Immunoregulation in Aging
Corona, A. W., Fenn, A. M., & Godbout, J. P. (2011) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-011-9313-4 · Cited by 94
Kovács, Z., D’Agostino, D. P., Diamond, D. M., Kindy, M. S., Rogers, C. Q., & Ari, C. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00363 · Cited by 93
Müller, N., Myint, A.-M., & Schwarz, M. (2012) · Advances in protein chemistry and structural biology · doi:10.1016/b978-0-12-398314-5.00003-9 · Cited by 95
Self-citationAnderson, G., Maes, M. H. J., & Berk, M. (2012) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2012.07.016 · Cited by 100
A Population‐Based Longitudinal Community Study of Major Depression and Migraine
Modgill, G., Jetté, N., Wang, J., Becker, W. J., & Patten, S. B. (2011) · Headache The Journal of Head and Face Pain · doi:10.1111/j.1526-4610.2011.02036.x · Cited by 84
Intercellular: local and systemic actions of skeletal muscle PGC-1s
Correia, J. C., Ferreira, D. M. S., & Ruas, J. L. (2015) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2015.03.010 · Cited by 95
Peripheral proinflammatory cytokines in Chinese patients with generalised anxiety disorder
Tang, Z., Ye, G., Chen, X., Pan, M., Fu, J., Fu, T., Liu, Q., Gao, Z., Baldwin, D. S., & Hou, R. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2017.08.082 · Cited by 83
Réus, G. Z., da Silva, R. H., de Moura, A. B., Presa, J. F., Abelaira, H. M., Abatti, M. R., Vieira, A. A. D. S., Pescador, B., Michels, M., Ignácio, Z. M., et al. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-1161-2 · Cited by 84
Glia in the cytokine-mediated onset of depression: fine tuning the immune response
Jo, W. K., Zhang, Y., Emrich, H. M., & Dietrich, D. E. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00268 · Cited by 77
Liu, D., Ray, B., Neavin, D. R., Zhang, J., Athreya, A. P., Biernacka, J. M., Bobo, W. V., Hall-Flavin, D. K., Skime, M. K., Zhu, H., et al. (2018) · Translational Psychiatry · doi:10.1038/s41398-017-0056-8 · Cited by 78
De Berardis, D., Conti, C. M. V., Serroni, N., Moschetta, F. S., Olivieri, L., Carano, A., Salerno, R. M., Cavuto, M., Farina, B., Alessandrini, M., et al. (2010) · International Journal of Immunopathology and Pharmacology · doi:10.1177/039463201002300204 · Cited by 77
Woo, Y., Seo, H.-J., McIntyre, R., & Bahk, W.-M. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17010080 · Cited by 79
“Activation of this enzyme leads to increased consumption of tryptophan, thus reducing the availability of serotonergic neurotransmission and inducing the production of detrimental tryptophan catabolites with neurotoxic effects [142].”
BackgroundHlavacova, N., Wes, P. D., Ondrejcakova, M., Flynn, M. E., Poundstone, P. K., Babic, S., Murck, H., & Jezova, D. (2012) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145711000368 · Cited by 74
Debnath, M., Berk, M., & Maes, M. H. J. (2021) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2021.110343 · Cited by 82
Epigenetics, a key for unlocking complex CNS disorders? Therapeutic implications
Szyf, M. (2015) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2014.01.009 · Cited by 76
“The response of the peripheral immune system to social adversity signals should not be surprising, as decades of studies have delineated bilateral relationship between the HPA axis and the immune system as well as between the immune system and brain function(Bellinger et al., 2008; Buske-Kirschbaum, 2009; Coe and Eric…”
BackgroundInflammation and depression but where does the inflammation come from?
Halaris, A. E. (2019) · Current Opinion in Psychiatry · doi:10.1097/yco.0000000000000531 · Cited by 80
Müller, N., Krause, D., Barth, R., Myint, A.-M., Weidinger, E., Stettinger, W., Zill, P., Drexhage, H., & Schwarz, M. J. (2019) · Journal of Affective Disorders · doi:10.1016/j.jad.2019.04.088 · Cited by 72
Self-citationInflammation and Immune Regulation as Potential Drug Targets in Antidepressant Treatment
Schmidt, F. M., Kirkby, K. C., & Lichtblau, N. (2016) · Current Neuropharmacology · doi:10.2174/1570159x14666160115130414 · Cited by 82
Guan, S. A., Bower, J. E., Almeida, D. M., Cole, S. W., Dahl, R. E., Irwin, M. R., Seeman, T. E., McDade, T. W., & Fuligni, A. J. (2016) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2016.03.007 · Cited by 76
MiR-335 is involved in major depression disorder and antidepressant treatment through targeting GRM4
Li, J., Meng, H., Cao, W., & Qiu, T. (2015) · Neuroscience Letters · doi:10.1016/j.neulet.2015.08.038 · Cited by 73
Ma, C., & Armstrong, A. W. (2013) · Journal of Dermatological Treatment · doi:10.3109/09546634.2013.813897 · Cited by 80
Role of tryptophan metabolism in cancers and therapeutic implications
Liu, X., & Zhai, X. (2021) · Biochimie · doi:10.1016/j.biochi.2021.01.005 · Cited by 77
Is there Progress? An Overview of Selecting Biomarker Candidates for Major Depressive Disorder
Young, J. J., Silber, T., Bruno, D., Galatzer-Levy, I. R., Pomara, N., & Marmar, C. R. (2016) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2016.00072 · Cited by 71
The role and mechanism of tryptophan – kynurenine metabolic pathway in depression
Gong, X., Chang, R., Zou, J., Tan, S., & Huang, Z. (2022) · Reviews in the Neurosciences · doi:10.1515/revneuro-2022-0047 · Cited by 78
Anti-inflammatory signaling in schizophrenia
Meyer, U. (2011) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2011.05.014 · Cited by 84
The association between immune activation and manic symptoms in patients with a depressive disorder
Becking, K., Boschloo, L., Vogelzangs, N., Haarman, B. C. M., Riemersma-van der Lek, R., Penninx, B. W. J. H., & Schoevers, R. A. (2013) · Translational Psychiatry · doi:10.1038/tp.2013.87 · Cited by 71
Düsedau, H. P., Steffen, J., Figueiredo, C. A., Boehme, J. D., Schultz, K., Erck, C., Körte, M., Faber‐Zuschratter, H., Smalla, K., Dieterich, D. C., et al. (2021) · mBio · doi:10.1128/mbio.01776-21 · Cited by 84
DNA Damage in Major Psychiatric Diseases
Raza, M. U., Tufan, T., Wang, Y., Hill, C. P., & Zhu, M. (2016) · Neurotoxicity Research · doi:10.1007/s12640-016-9621-9 · Cited by 75
Analyzing chronic disease biomarkers using electrochemical sensors and artificial neural networks
Sinha, K., Uddin, Z., Kawsar, H. I., Islam, S., Deen, M. J., & Howlader, M. M. R. (2022) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2022.116861 · Cited by 76
Interleukin-1β Serum Levels is Increased in Antidepressant-Free Elderly Depressed Patients
Diniz, B. S., Teixeira, A. L., Talib, L. L., Gattaz, W. F., & Forlenza, O. V. (2010) · American Journal of Geriatric Psychiatry · doi:10.1097/jgp.0b013e3181c2947f · Cited by 72
Ahmetspahic, D., Schwarte, K., Ambrée, O., Bürger, C., Falcone, V., Seiler, K., Kooybaran, M. R., Grosse, L., Roos, F., Scheffer, J., et al. (2017) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-017-9763-4 · Cited by 71
Inflammation Theories in Psychotic Disorders: A Critical Review
Suvisaari, J., & Mantere, O. (2013) · Infectious Disorders - Drug Targets · doi:10.2174/18715265112129990032 · Cited by 66
Cocaine promotes oxidative stress and microglial-macrophage activation in rat cerebellum
López‐Pedrajas, R., Ramírez-Lamelas, D. T., Muriach, B., Sanchez‐Villarejo, M. V., Almansa, I., Vidal‐Gil, L., Romero, F. J., Barcia, J. M., & Muriach, M. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00279 · Cited by 71
Plasma polyunsaturated fatty acids and regional cerebral glucose metabolism in major depression
Elizabeth Sublette, M., Milak, M. S., Hibbeln, J. R., Freed, P. J., Oquendo, M. A., Malone, K. M., Parsey, R. V., & John Mann, J. (2009) · Prostaglandins, Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2008.11.004 · Cited by 65
Opioid system influences gut-brain axis: Dysbiosis and related alterations
Rueda‐Ruzafa, L., Cruz, F., Cardona, D., Hone, A. J., Molina‐Torres, G., Sánchez‐Labraca, N., & Román, P. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.104928 · Cited by 70
Alesci, A., Lauriano, E. R., Fumia, A., Irrera, N., Mastrantonio, E., Vaccaro, M., Gangemi, S., Santini, A., Cicero, N., & Pergolizzi, S. (2022) · Molecules · doi:10.3390/molecules27061953 · Cited by 70
Ionescu, C. E., Popescu, C. C., Agache, M., Dinache, G., & Codreanu, C. (2022) · Medicina · doi:10.3390/medicina58111637 · Cited by 70
Metadata
- Authors
- Müller, N., & Schwarz, M. J.
- Affiliations
- Ludwig-Maximilians-Universität München (DE)
- Venue
- Molecular Psychiatry
- Published
- 2007-04-24
- Volume
- 12
- Issue
- 11
- Pages
- 988-1000
- ISSN
- 1359-4184 (ISSN-L)
- 1476-5578
- OpenAlex
- W2002250647
- Cited by
- 670
- References
- 220
- Citations by year
- 2026: 14 · 2025: 22 · 2024: 30 · 2023: 31 · 2022: 48 · 2021: 41 · 2020: 37 · 2019: 34 · 2018: 42 · 2017: 25 · 2016: 49 · 2015: 34 · 2014: 39 · 2013: 32 · 2012: 33
- FWCI
- 1.44
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Molecular Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Keywords
- major depressive disorder, serotonin, glutamate, indoleamine 2,3-dioxygenase, kynurenine pathway, quinolinic acid, NMDA receptor, inflammatory cytokines, microglia, astrocytes, tryptophan metabolism, hypothalamic-pituitary-adrenal axis, immune activation, antidepressants, COX-2 inhibitors
- MeSH terms
- Animals, Depression, Humans, Hypothalamo-Hypophyseal System, Immune System, Pituitary-Adrenal System, Serotonin, Glutamic Acid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.